Lipoic acid/Mecobalamin/Vitamin B1/Vitamin B6

Tier C — Watch / trade

BREGO Life Sciences Sdn Bhd

Originator

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：PDHK, DNMT1

Brand：Bionerv

Indications (approved)：Diabetic neuropathy

Regional status

China

Japan

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Also available in our peptide catalogue

vitamin B12

1 code$19.85

Frequently asked questions

What are the approved indications of Lipoic acid/Mecobalamin/Vitamin B1/Vitamin B6?

Approved indications include: Diabetic neuropathy.

When does the Lipoic acid/Mecobalamin/Vitamin B1/Vitamin B6 patent expire?

No public expiry year is available for Lipoic acid/Mecobalamin/Vitamin B1/Vitamin B6 yet; this page updates once verified.

How do I get a quote for Lipoic acid/Mecobalamin/Vitamin B1/Vitamin B6 intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-01